R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids-Reference-Cited by-同舟云学术

R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids

Published:2010-05-13 Issue:5 Volume:5 Page:e10628
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bishay Philipp,Schmidt Helmut,Marian Claudiu,Häussler Annett,Wijnvoord Nina,Ziebell Simone,Metzner Julia,Koch Marco,Myrczek Thekla,Bechmann Ingo,Kuner Rohini,Costigan Michael,Dehghani Faramarz,Geisslinger Gerd,Tegeder Irmgard

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain.;W Ma;Expert Opin Ther Targets,2007

2. Neuroimmune interactions and pain: focus on glial-modulating targets.;EA Romero-Sandoval;Curr Opin Investig Drugs,2008

3. Cyclooxygenase-independent actions of cyclooxygenase inhibitors.;I Tegeder;Faseb J,2001

4. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study.;G Geisslinger;J Neurochem,2000

5. Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen.;I Tegeder;Faseb J,2001

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multichiral Mesoporous Silica Screws with Chiral Differential Mucus Penetration and Mucosal Adhesion for Oral Drug Delivery;ACS Nano;2024-06-13

2. NAPE-PLD regulates specific baseline affective behaviors but is dispensable for inflammatory hyperalgesia;Neurobiology of Pain;2023-08

3. Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain;Cells;2023-04-27

4. Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential;Current Medicinal Chemistry;2023-04

5. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities;Progress in Lipid Research;2023-01